This multidimensional network of interactions positions AMPK as a central hub linking energy sensing, metabolic regulation, and inflammatory responses, offering multiple therapeutic targets for the precise intervention of NAFLD. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.